The role of somatostatin analogs in the management of hepatocellular carcinoma
- PMID: 15233229
The role of somatostatin analogs in the management of hepatocellular carcinoma
Similar articles
-
Somatostatin receptor expression in hepatocellular carcinoma: prognostic and therapeutic considerations.Endocr Relat Cancer. 2014;21(6):R485-93. doi: 10.1530/ERC-14-0389. Epub 2014 Oct 21. Endocr Relat Cancer. 2014. PMID: 25336571 Review.
-
Octreotide and hepatocellular carcinoma.Br J Cancer. 2007 Jun 4;96(11):1778-9. doi: 10.1038/sj.bjc.6603799. Epub 2007 May 15. Br J Cancer. 2007. PMID: 17505506 Free PMC article. Clinical Trial. No abstract available.
-
[Somatostatin analogue (octreotide)].Nihon Rinsho. 2001 Oct;59 Suppl 6:674-7. Nihon Rinsho. 2001. PMID: 11762035 Review. Japanese. No abstract available.
-
Somatostatin and hepatocellular carcinoma.Gastroenterology. 1998 Nov;115(5):1298-9. doi: 10.1016/s0016-5085(98)70109-x. Gastroenterology. 1998. PMID: 9797392 Clinical Trial. No abstract available.
-
Treatment of Advanced Hepatocellular Carcinoma with Somatostatin Analogues: A Review of the Literature.Int J Mol Sci. 2019 Sep 27;20(19):4811. doi: 10.3390/ijms20194811. Int J Mol Sci. 2019. PMID: 31569719 Free PMC article. Review.
Cited by
-
The GH-IGF-SST system in hepatocellular carcinoma: biological and molecular pathogenetic mechanisms and therapeutic targets.Infect Agent Cancer. 2014 Aug 20;9:27. doi: 10.1186/1750-9378-9-27. eCollection 2014. Infect Agent Cancer. 2014. PMID: 25225571 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical